Aimmune Therapeutics to Present New Data for PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] at the EAACI Hybrid Congress 2022

— Analysis to be Presented Showed Peanut Allergy Treatment with PALFORZIA was Associated with Improvements in Health-Related Quality of Life among Patients and Caregivers— —Additional Data to be Presented Suggested Increased Satisfaction Rates Associated with Convenience and Effectiveness of PALFORZIA Treatment— BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc., a Nestlé Health Science company developing pharmaceutical therapies to … [Read more…]

Emerson Strengthens Leadership in Life Sciences Industry with Acquisition of Fluxa

Acquisition complements Emerson’s software and technology portfolio and helps accelerate delivery of life-saving medicines ST. LOUIS–(BUSINESS WIRE)–Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on … [Read more…]

Francisco Partners Completes Acquisition of IBM’s Healthcare Data and Analytics Assets; Launches Healthcare Data Company Merative

Merative will deliver industry-leading data and technology across the healthcare value chain SAN FRANCISCO–(BUSINESS WIRE)–Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has completed the acquisition of healthcare data and analytics assets that were part of IBM’s (NYSE: IBM) Watson Health business, previously announced in … [Read more…]

IDEX Corporation to Webcast Second Quarter 2022 Earnings Call

NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company’s second quarter earnings conference call over the Internet on Wednesday, July 27, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company’s second … [Read more…]

Geron Corporation Announces Expansion of Existing Loan Facility

Up to $50 Million in Additional Non-Dilutive Capital Potentially Available in 2023 FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced an amendment to expand its existing loan facility with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank, from up to $75 million to up to $125 million. “This … [Read more…]

Leading Independent Advisory Firm Glass Lewis Joins ISS in Recommending Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., today announced that a second leading independent firm, Glass Lewis, has recommended that shareholders vote “FOR” the previously announced transaction … [Read more…]

Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.

SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022. Management will hold a conference call to review the company’s second quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be … [Read more…]

ROME Therapeutics Announces Publication of First Crystal Structure of a Human Endogenous Reverse Transcriptase in PNAS

Study reveals first-ever structure of a non-viral endogenous reverse transcriptase (eRT) Human endogenous retrovirus-K (HERV-K) RT shows striking similarity to HIV RT Findings enable structure-based drug discovery for eRTs CAMBRIDGE, Mass.–(BUSINESS WIRE)–ROME Therapeutics, a biotechnology company harnessing the power of the dark genome for drug development, today announced a new publication in The Proceedings of … [Read more…]

ICPO Foundation presents its first Maurits W. Geerlings Actinium-225 Next Generation Award to Dr. Madhav Yadav from AIIMS, India at the 6th Theranostics World Congress (TWC)

WIESBADEN, Germany–(BUSINESS WIRE)–The International Centers for Precision Oncology (ICPO) Foundation is pleased to announce that its first Maurits W. Geerlings Next Generation Award presentation for Outstanding Research and Contributions to Actinium-225 Radiopharmaceuticals took place on Friday, June 24 during the 6th TWC in Wiesbaden, Germany (Congress President: Professor Dr. Richard P. Baum). Named after the … [Read more…]

Provincial Government Uninterested in Meaningful Negotiations with Long-Term Care Workers: CUPE

HALIFAX, Nova Scotia–(BUSINESS WIRE)–The union representing the majority of long-term care workers in the province, CUPE Nova Scotia, says that conciliation efforts have failed, and negotiations with the provincial government have reached an impasse. The conciliation officer’s report to the Minister of Labour will be filed on July 8, setting in motion possible job action. … [Read more…]